[Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities]
- PMID: 40599294
- PMCID: PMC12207050
- DOI: 10.12182/20250360504
[Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities]
Abstract
Osteoporosis and cardiovascular calcification, two major age-related chronic diseases that China is confronting today, pose serious threats to public health. Previous studies have reported overlapping connections in the pathological processes and molecular mechanisms of these two diseases, particularly concerning inflammation, oxidative stress, and dysregulation of mineral metabolism, and that these two diseases tend to share common pathogenic factors. However, research exploring the comorbidity mechanisms of the two diseases remains limited in both depth and scope, largely due to the lack of widely accepted comorbidity animal models. Herein, we analyzed the latest research findings on the comorbidity mechanisms of vascular calcification and osteoporosis, focusing on summarizing the animal disease models currently in extensive use and the relevant evaluation criteria. We aim to provide new references for comorbidity research models and offer scientific evidence for future studies on pathological mechanisms and the development of new therapeutic strategies.
骨质疏松与心血管钙化是当今中国社会常见的两个重大老年性慢病,严重危害公共健康。现有研究表明,这两种疾病在病理进程和分子机制上存在交叉联系,尤其在炎症、氧化应激以及矿物质代谢失调等方面,往往有共同的致病因素。然而现有研究对两种疾病的共病机制探索不够深入和广泛,限制其深入研究的因素可能是缺乏被广泛认可的共病动物模型。本文分析了血管钙化和骨质疏松共病机制的最新研究进展,并侧重总结当前广泛应用的动物疾病模型和相关评价标准,为共病研究模型提供新的参考,同时为未来的病理机制研究和新的治疗策略开发提供科学依据。
Keywords: Animal models; Osteoporosis; Review; Vascular calcification.
© 2025《四川大学学报(医学版)》编辑部 Copyright ©2025 Journal of Sichuan University (Medical Science Edition).
Conflict of interest statement
利益冲突 本文作者刘肖珩是本刊编委会编委。该文在编辑评审过程中所有流程严格按照期刊政策进行,且未经其本人经手处理。除此之外,所有作者均声明不存在利益冲突。
Figures
Similar articles
-
Parathyroidectomy for adults with primary hyperparathyroidism.Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2. Cochrane Database Syst Rev. 2023. PMID: 36883976 Free PMC article.
-
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4. Cochrane Database Syst Rev. 2022. PMID: 35502787 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Bisphosphonates for steroid-induced osteoporosis.Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2. Cochrane Database Syst Rev. 2016. PMID: 27706804 Free PMC article.
-
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500. Health Technol Assess. 2012. PMID: 23302507 Free PMC article.
References
-
- Den UYL D, NURMOHAMED M T, Van TUYL L H, et al (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther. 2011;13(1):R5. doi: 10.1186/ar3224. - DOI - PMC - PubMed
-
-
ADEJUYIGBE B, KALLINI J, CHIOU D, et al. Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci, 2023, 24(19): 14583.
-
-
-
ISERI K, QURESHI A R, DAI L, et al. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: a cohort study. Bone, 2020, 130: 115075.
-
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical